scorecard
  1. Home
  2. Science
  3. Health
  4. news
  5. What's at stake for Apple's future in healthcare

What's at stake for Apple's future in healthcare

Leah Rosenbaum   

What's at stake for Apple's future in healthcare

Hello,

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and this week in healthcare news:

  • We went deep inside Apple's health organization, where there have been a $4;
  • We found the top new serial biotech entrepreneurs to watch, all $4;
  • Deep reporting revealed how patients are trying to pry back their health records from $4.

If you're new to this newsletter, $4 Comments, tips? Email me at lrosenbaum@insider.com or tweet $4 Let's get to it...


$4

$4

Apple, the world's most valuable company, has been trying to break into the healthcare scene for more than half a decade. So why hasn't it gotten as far as its competitors, Google and Amazon?

Investigative reporting by Blake Dodge found that $4 by high-level departures, setbacks and deep organizational problems.

$4

$4


Meet the next generation of biotech's serial entrepreneurs >$4

It's not uncommon for biotech companies to have founders in common. Some preeminent entrepreneurs like George Church or Robert Langer have had a hand in the founding of dozens of successful companies.

Now, Allison DeAngelis reveals the $4.

They're all under 45, and have started at least three companies. Keep an eye on them - we're betting they are going to do big things.

$4

$4


Patient advocates are fighting medical record giants for access to their own health data>$4

Patient medical records across the US are fragmented - meaning that your full medical history often isn't accessible in different hospital systems.

As Mohana Ravindranath reveals, this can lead to dangerous situations.

But Mohana reports that there is a $4 who are fighting to pry their medical records back from the hold of software giants like Epic and Cerner.

It's a David and Goliath story between patients and a $14.5 billion industry.

$4

$4


More stories that kept us busy this week:

  • Andy Dunn discussed why the success of COVID-19 vaccines has led other biotechs to $4
  • Arch Venture Partners has founded a new mega biotech, reports Allison, this time $4.
  • Dermatologists are moving online, reports Jade Khatib; here's how they're $4 to fight misinformation.
  • Megan Hernbroth brought us two new pitch decks that helped $4 and $4 raise millions.

-Leah

READ MORE ARTICLES ON



Popular Right Now



Advertisement